Zurück
Klinik für Psychiatrie, Psychosomatik und Psychotherapie
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy
University of Frankfurt
Heinrich-Hoffmann-Straße 10
60528 Frankfurt am Main
PD Dr. Florian Freudenberg
Tel.: 069/6301-85665
florian.freudenberg@unimedizin-ffm.de
Our research group is interested in identifying the molecular mechanisms involved in the development of psychiatric disorders, particularly those with an onset in adolescence and early adulthood (i.e. schizophrenia, affective disorders, and ADHD). Our main focus are the synaptic mechanisms of the glutamatergic synapse with a particular interest on proteins and protein-protein interactions. The main target here is the protein network encompassing AMPA and NMDA receptors, their auxiliary subunits, as well as neuronal nitric oxide synthase (NOS-I) and its adapter protein (NOS1AP) and their interaction partners. In addition, we investigate the effect of environmental factors (e.g. stress, inflammation, drug abuse) on these molecular targets, and how environmental and genetic factors interact to cause psychiatric disorders. By targeting these pathways, genetically and pharmacologically, we aim to identify the aetiology as well as novel treatment opportunities for these disorders.
To investigate these mechanisms, we utilize a wide range of methods, including behavioural and molecular phenotyping of mice, cell culture models, in vitro and in vivo viral gene transfer, morphological and histological analyses, as well as the genetic and molecular investigation of human biosamples. Moreover, in collaboration with Prof. Dr. Michael Plichta, we are investigating the effects of genetic variants on behavioural performance in human subject.
Watch this Instagram Reel from the Goethe University Career Service showing the average day in the life of our very own Melike Aydin (BSc student in 2023)
Selection of current projects:
For a complete list of publications see Google scholar.
Candemir, E., Fattakhov, N., Leary, A. O., Slattery, D. A., Courtney, M. J., Reif, A., & Freudenberg, F. (2023). Disrupting the nNOS/NOS1AP interaction in the medial prefrontal cortex impairs social recognition and spatial working memory in mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 67, 66–79. https://doi.org/10.1016/j.euroneuro.2022.11.006
Freudenberg, F., Althen, H., Falk, K., Bittner, R. A., Reif, A., & Plichta, M. M. (2022). Test-retest reliability of prepulse inhibition (PPI) and PPI correlation with working memory. Acta neuropsychiatrica, 34(6), 344–353. https://doi.org/10.1017/neu.2022.19
O'Leary, A., Fernàndez-Castillo, N., Gan, G., Yang, Y., Yotova, A. Y., Kranz, T. M., Grünewald, L., Freudenberg, F., Antón-Galindo, E., Cabana-Domínguez, J., Harneit, A., Schweiger, J. I., Schwarz, K., Ma, R., Chen, J., Schwarz, E., Rietschel, M., Tost, H., Meyer-Lindenberg, A., Pané-Farré, C. A., … Reif, A. (2022). Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits. Molecular psychiatry, 27(11), 4464–4473. https://doi.org/10.1038/s41380-022-01722-4
Esen-Sehir, D., Kopf, J., Hägele, S., Plichta, M. M., Reif, A., & Freudenberg, F. (2022). Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia. Pharmacopsychiatry, 10.1055/a-1811-7241. Advance online publication. https://doi.org/10.1055/a-1811-7241
Freudenberg, F., Candemir, E., Chen, X., Li, L. L., Esen-Sehir, D., Schenk, N., Kinoshita, M., Grünewald, L., Frerichs, V., Fattakhov, N., Manchen, J., Bikas, S., Kumar, A., OLeary, A., Slattery, D. A., von Engelhardt, J., Courtney, M. J., & Reif, A. (2021). Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders. EBioMedicine, 71, 103565. https://doi.org/10.1016/j.ebiom.2021.103565
Esen-Sehir, D., Courtney, M. J., Bittner, R. A., Reif, A., & Freudenberg, F. (2019). Establishing an effective dose for chronic intracerebroventricular administration of clozapine in mice. Acta neuropsychiatrica, 31(6), 305–315. https://doi.org/10.1017/neu.2019.31
Grünewald, L., Chiocchetti, A. G., Weber, H., Scholz, C. J., Schartner, C., Freudenberg, F., & Reif, A. (2021). Knockdown of the ADHD Candidate Gene Diras2 in Murine Hippocampal Primary Cells. Journal of attention disorders, 25(4), 572–583. https://doi.org/10.1177/1087054718822129
Candemir, E., Kollert, L., Weißflog, L., Geis, M., Müller, A., Post, A. M., O'Leary, A., Harro, J., Reif, A., & Freudenberg, F. (2016). Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 26(4), 741–755. https://doi.org/10.1016/j.euroneuro.2016.01.008
Freudenberg, F., Celikel, T., & Reif, A. (2015). The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?. Neuroscience and biobehavioral reviews, 52, 193–206. https://doi.org/10.1016/j.neubiorev.2015.03.005
Freudenberg, F., Alttoa, A., & Reif, A. (2015). Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes, brain, and behavior, 14(1), 46–63. https://doi.org/10.1111/gbb.12193
Unsere Webseite verwendet Cookies. Diese haben zwei Funktionen: Zum einen sind sie erforderlich für die grundlegende Funktionalität unserer Website. Zum anderen können wir mit Hilfe der Cookies unsere Inhalte für Sie immer weiter verbessern. Hierzu werden pseudonymisierte Daten von Website-Besuchern gesammelt und ausgewertet. Das Einverständnis in die Verwendung der Cookies können Sie jederzeit widerrufen. Weitere Informationen zu Cookies auf dieser Website finden Sie in unserer Datenschutzerklärung und zu uns im Impressum.
Hier gelangen Sie zu den Cookie-Einstellungen.